Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.75ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.75ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.75NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.51ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-829.135France
B.51ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.51ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.51NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.106ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.106ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.106ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.106NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
D.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
D.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
D.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
D.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.593ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.593ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.593ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.593NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.438.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.438.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.438.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.438.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.290ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.290ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.290ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.290NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.341ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.341ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.341ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.341NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.161ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.161ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.161ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.161NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.69 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.69 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.69 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.69 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.46ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.46NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.139ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.139ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.139ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.139NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.508ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.508ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.508ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used